Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Int J Mol Sci ; 22(19)2021 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-34638994

RESUMEN

The authors present their contribution to the improvement of methods suitable for the detection of the freezing and thawing damage of cells of cryopreserved venous grafts used for lower limb revascularization procedures. They studied the post-thaw viability of cells of the wall of cryopreserved venous grafts (CVG) immediately after thawing and after 24 and 48 h culture at +37 °C in two groups of six CVG selected randomly for slow thawing in the refrigerator and rapid thawing in a water bath at +37 °C. The grafts were collected from multi-organ and tissue brain-dead donors, cryopreserved, and stored in a liquid nitrogen vapor phase for five years. The viability was assessed from tissue slices obtained by perpendicular and longitudinal cuts of the thawed graft samples using in situ staining with fluorescence vital dyes. The mean and median immediate post-thaw viability values above 70% were found in using both thawing protocols and both types of cutting. The statistically significant decline in viability after the 48-h culture was observed only when using the slow thawing protocol and perpendicular cutting. The possible explanation might be the "solution effect damage" during slow thawing, which caused a gentle reduction in the graft cellularity. The possible influence of this phenomenon on the immunogenicity of CVG should be the subject of further investigations.


Asunto(s)
Aloinjertos/diagnóstico por imagen , Criopreservación/métodos , Vena Femoral/diagnóstico por imagen , Colorantes Fluorescentes , Congelación , Imagen Óptica/métodos , Vena Safena/diagnóstico por imagen , Aloinjertos/efectos de los fármacos , Apoptosis/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Crioprotectores/farmacología , Dimetilsulfóxido/farmacología , Vena Femoral/efectos de los fármacos , Humanos , Microscopía Confocal/métodos , Vena Safena/efectos de los fármacos , Donantes de Tejidos , Injerto Vascular/métodos
2.
Viruses ; 10(10)2018 10 20.
Artículo en Inglés | MEDLINE | ID: mdl-30347798

RESUMEN

The envelope glycoprotein (Env) plays a crucial role in the retroviral life cycle by mediating primary interactions with the host cell. As described previously and expanded on in this paper, Env mediates the trafficking of immature Mason-Pfizer monkey virus (M-PMV) particles to the plasma membrane (PM). Using a panel of labeled RabGTPases as endosomal markers, we identified Env mostly in Rab7a- and Rab9a-positive endosomes. Based on an analysis of the transport of recombinant fluorescently labeled M-PMV Gag and Env proteins, we propose a putative mechanism of the intracellular trafficking of M-PMV Env and immature particles. According to this model, a portion of Env is targeted from the trans-Golgi network (TGN) to Rab7a-positive endosomes. It is then transported to Rab9a-positive endosomes and back to the TGN. It is at the Rab9a vesicles where the immature particles may anchor to the membranes of the Env-containing vesicles, preventing Env recycling to the TGN. These Gag-associated vesicles are then transported to the plasma membrane.


Asunto(s)
Productos del Gen env/metabolismo , Virus del Mono Mason-Pfizer/fisiología , Síndrome de Inmunodeficiencia Adquirida del Simio/virología , Vesículas Transportadoras/virología , Animales , Membrana Celular/metabolismo , Membrana Celular/virología , Endosomas/metabolismo , Endosomas/virología , Productos del Gen env/genética , Virus del Mono Mason-Pfizer/genética , Transporte de Proteínas , Vesículas Transportadoras/metabolismo , Ensamble de Virus
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA